8:30 am – 9:20 am
Registration and Continental Breakfast
9:20 am – 9:30 am
Welcoming Remarks, Christopher J. Kemper, Chair, DV DMDG
9:30 am – 10:20 am
Dr. Michael Carver, Wyeth Research, Andover, MA:
"Current Practice of Toxicogenomics in the Pharmaceutical
Industry".
10:20 am – 11:10 am
Dr. Roland Wolf, Director, University of Dundee Biomedical
Research Centre: "Application of in vitro and in vivo
transgenic models to drug development".
11:10 am – 11:30 am
Coffee & Tea Break
11:30 am – 12:20 pm
Dr. Thomas Tephly, Univ. of Iowa:
"Human UDP-Glucuronosyltransferases: Substrates, Inhibitors
and Active Sites".
12:20 am – 1:30 pm
Buffet Lunch
1:30 pm – 2:20 pm
Dr. Dennis Heller, Pharmaceutical Profiles:
"Using Human Scintigraphic Imaging to Probe the Delivery and
Absorption of Complex Oral Dosage Forms – A Tool to Improve
Decision Making in Early Drug Development".
2:20 pm – 3:10 pm
Dr. Martin Pomper, Johns Hopkins University School of
Medicine:
"Molecular Imaging in Drug Development".
3:10 pm – 3:30 pm
Coffee & Tea Break
3:30 pm – 4:20 pm
Dr. Bradford Jensen, Aventis:
"Practical Pharmacokinetics: Consequences of Experimental
Design".
4:20 pm – 4:30 pm
Final Remarks: Christopher J. Kemper, Chair, DV DMDG
4:30 pm – 5:30 pm
Reception and Cash Bar
9:00 am to 5:00 pm: Displays:
Software for Drug Metabolism/Pharmacokinetics
with vendors: LC Resources, InnaPhase, Intellipharm
also invited: Camitro, PharSight, Simulations Plus